Leave Your Message

A Comprehensive Overview of Groundbreaking Leukemia Treatment

CAR-T Therapy, short for Chimeric Antigen Receptor T-Cell Immunotherapy, is an advanced gene therapy method that involves genetically modifying a patient's own T cells to target and destroy cancer cells. Unlike traditional medications, CAR-T therapy is tailored to each patient and requires collecting T cells from the patient's blood before reinfusing them back into the body after genetic engineering.

    Indications of CAR-T

    B-cell acute lymphoblastic leukemia

     Multiple myeloma

     Chronic lymphocytic leukemia

     Non-Hodgkin lymphoma

     Diffuse large B-cell lymphoma

     SLE(Systemic Lupus Erythematosus)

     Myasthenia gravis

     Other autoimmune diseases

    Excellent CAR-T clinical performance

    Indications for CD19+20CAR-T: Patients with B-cell non Hodgkin's lymphoma

    One month CR rate

    One month PR rate

    One month OR rate

    CRS≥3

    CRES≥3

    71.95%(59/82)

    25.6(21/82)

    97.55(80/82)

    12.19%(10/82)

    0

    Indications for CD19+22CAR-T: Treatment of CD19 relapsed and refractory acute B-lymphocytic leukemia patients

    One month CR rate

    One month PR rate

    One month OR rate

    CRS≥3

    CRES≥3

    92.1%(35/38)

    7.9%(3/38)

    100%(38/38)

    15.79%(6/38)

    0

    Indications for BCMACAR-T: Treatment of relapsed and refractory multiple myeloma

    One month CR rate

    One month PR rate

    One month OR rate

    CRS≥3

    CRES≥3

    72.41%(21/29)

    27.59%(8/29)

    100%(29/29)

    6.9%(2/29)

    0

    CAR-T THERAPY OVERVIEW (2)tch

    Our Advantages

     Personalized Treatment: We customize CAR-T therapy for each patient, ensuring targeted and effective treatment.

     Diverse Targeting Options: Our CAR-T products offer a wide range of target options, including CD7, CD19, CD20, CD22, and BCMA, providing the advantage of personalized treatment options for patients.

     Cutting-edge Technology: Our CAR-T therapy utilizes the latest advancements in genetic engineering and immunotherapy.

     High cost-effectiveness: Compared to other products, we offer a superior balance between quality assurance and competitive pricing.

     Clinical Expertise: Backed by a team of experienced clinicians and researchers, we deliver high-quality care and support throughout the treatment process.

     Comprehensive Approach: We offer comprehensive care, from patient evaluation to therapy administration and follow-up, ensuring optimal outcomes.

    Nowadays, CAR-T cells are applied for patients who have had other standard treatments without getting expected results, include chemo or bone marrow transplantation. The therapeutic effects of CAR-T have been widely acknowledged across the globe.

    description2

    Fill out my online form.